Clinical Evidence for Tirzepatide's Appetite Control Benefits The SURMOUNT clinical trial series demonstrated that tirzepatide-treated patients reduced their daily calorie intake by an average of 500800 calories compared to placebo, with this reduction occurring largely through decreased hunger rather than willpower or food restriction
GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and the GIP/GLP-1 dual agonist tirzepatide were studied in STEP (NEJM 2021), SURMOUNT (NEJM 2022), and SURMOUNT-OSA (NEJM 2024)
PlexusDx's approach focuses on finding your individual thresholdthe dose where you lose weight effectively without paying more as your treatment advances
Standard brand-name doses may include tirzepatide 5 mg, tirzepatide 10 mg, and tirzepatide 15 mg after a gradual titration period
Our product, Refluxter, contains more sodium alginate per dose than any other U.S
Re-evaluation and Monitoring Its wise to periodically evaluate how youre doing on the plan